Limited low-air insufflation is optimal for colonoscopy.
BACKGROUND
Air insufflation is essential in routine colonoscopy, but obtaining optimal insufflation levels has not been discussed in the literature. The aim of this study was to determine optimal air insufflation during colonoscopic examination.


METHODS
Consecutive patients who underwent colonoscopy were randomized to receive high-air insufflation (group A, n = 83), low-air insufflation (group B, n = 84), or low-air insufflation limited to the rectum and sigmoid colon (group C, n = 83). Completion rate, cecal intubation time, propofol dose, need for abdominal compression, and turning of patients, were evaluated. The post-procedure abdominal bloating was assessed with a 0-10 visual analog scale.


RESULTS
The completion rates were similar among the three groups. The cecal intubation time was significantly shorter in group C than in group B (4.1 +/- 1.7 min vs. 5.2 +/- 3.0 min, mean +/- SD, p = 0.005). The dose of propofol was significantly less in group C than in group A (11.7 +/- 3.2 mg vs. 12.7 +/- 3.6 mg, mean +/- SD, p = 0.045). Group C needed the least manual abdominal compression (group A, B, and C: 81.9, 69, and 59%, respectively, p = 0.005) and had the least post-procedure abdominal bloating (group A, B, and C: 2.2 +/- 2.4, 2.2 +/- 2.1, and 1.5 +/- 1.9, respectively, p = 0.04).


CONCLUSIONS
We found that limited use of low-air insufflation in the rectum and sigmoid is the procedure of choice for colonoscopic examination.
Hsieh
Yu-Hsi
YH
Division of Gastroenterology, Department of Medicine, Buddhist Dalin Tzu Chi General Hospital, Chia-Yi, Taiwan.
Tseng
Kuo-Chih
KC
Lin
Hwai-Jeng
HJ
D000328:Adult; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D003113:Colonoscopy / Q000379:methods*; D016292:Procedural Sedation / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007327:Insufflation / Q000379:methods; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D011028:Pneumoperitoneum, Artificial / Q000379:methods*; D011336:Probability; D015742:Propofol / Q000008:administration & dosage; D011446:Prospective Studies; D018570:Risk Assessment; D013997:Time Factors
D015742:Propofol
Am J Gastroenterol. 2000 Oct;95(10):2784-7
11051348
Endoscopy. 2006 Mar;38(3):214-7
16528645
Gastrointest Endosc. 1991 Mar-Apr;37(2):152-4
2032598
Lancet. 2000 Nov 18;356(9243):1718-22
11095259
Gastroenterology. 1997 Jan;112(1):17-23
8978337
Gastrointest Endosc. 2002 Aug;56(2):190-4
12145595
Gastrointest Endosc. 1986 Oct;32(5):324-9
3095168
Aliment Pharmacol Ther. 2007 Aug 15;26(4):627-31
17661766
Endoscopy. 1999 May;31(4):314-7
10376459
Gastrointest Endosc. 1997 Nov;46(5):444-6
9402119
Gastrointest Endosc. 2000 Jan;51(1):33-6
10625792
Gastrointest Endosc. 2003 Aug;58(2):203-6
12872086
Gastrointest Endosc. 2005 Jan;61(1):72-5
15672059
Gastrointest Endosc. 1992 Sep-Oct;38(5):564-7
1397911
Br Med J (Clin Res Ed). 1988 Jan 16;296(6616):167-9
3122983
Gut. 2000 Jun;46(6):801-5
10807891
Endoscopy. 2002 Jun;34(6):435-40
12048623
Gastrointest Endosc. 2002 Nov;56(5):672-4
12397274
Am J Gastroenterol. 2008 Mar;103(3):581-7
18076732
Gastrointest Endosc. 2000 Jul;52(1):1-8
10882954
Am J Gastroenterol. 2001 Jan;96(1):95-100
11197295
Am J Gastroenterol. 2006 Dec;101(12):2866-77
17227527
Dig Dis Sci. 2009 Sep;54(9):1997-2001
19058003
Anaesthesia. 1986 Jun;41(6):640-3
3089052
Gastrointest Endosc. 1996 Feb;43(2 Pt 1):124-6
8635705
Gastrointest Endosc. 2002 Dec;56(6):825-8
12447292
Gastrointest Endosc. 2005 Jan;61(1):37-45
15672054
Postgrad Med J. 1985;61 Suppl 3:157-9
3877285
Am J Gastroenterol. 2002 Dec;97(12):3052-5
12492189